Jiangmen Central Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Established: 1912-01-01

Employees: -

Market Cap: -

Website: http://www.bjch.com/

Clinical Trials

Toripalimab Combined With Gemcitabine/5--fluoropyrimidine for Advanced Cholangiocarcinoma

Phase 2

Conditions: Advanced Cholangiocarcinoma

Interventions: Drug: Toripalimab
Drug: Gemcitabine
Drug: 5- fluorine pyrimidine

First Posted Date: 2019-06-11

Last Posted Date: 2019-07-16

Lead Sponsor: Jiangmen Central Hospital

Target Recruit Count: 30

Registration Number: NCT03982680

Locations: 🇨🇳
Jiangmen central hospital, Jiangmen, Guangdong, China

The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer

Phase 2

Conditions: Breast Cancer

Interventions: Drug: gefitinib

First Posted Date: 2012-11-22

Last Posted Date: 2012-12-03

Lead Sponsor: Jiangmen Central Hospital

Target Recruit Count: 50

Registration Number: NCT01732276

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy